Table 3.
Antimicrobial Activity of Sorrel on E. coli O157:H7 from Clinical Samples
| |
|
Zones of inhibition (mm) |
||
|---|---|---|---|---|
| E. coli O157:H7 isolates | Source | 2.5% sorrel | 5% sorrel | 10% sorrel |
| MF-AAMU-25 | Clinical | 9.49±0.1c | 10.83±0.0d | 13.26±0.1c |
| MF-AAMU-27 | Clinical | 7.66±0.2e | 11.61±0.1c | 14.53±0.1b |
| MF-AAMU-28 | Clinical | 7.75±0.0e | 9.52±0.2e | 13.59±0.1c |
| MF-AAMU-29 | Clinical | 8.81±0.0d | 9.56±0.0e | 14.84±0.1b |
| MF-AAMU-30 | Clinical | 9.43±0.2c | 12.4±0.1b | 14.65±0.0b |
| MF-AAMU-32 | Clinical | 7.40±0.2e | 12.82±0.4b | 13.44±0.2c |
| MF-AAMU-33 | Clinical | 9.26±0.1c | 10.56±0.1d | 12.90±0.2d |
| MF-AAMU-36 | Clinical | 9.21±0.0c | 10.63±0.2d | 12.37±0.5d |
| MF-AAMU-37 | Clinical | 9.87±0.2c | 10.26±0.1d | 11.47±0.1e |
| MF-AAMU-38 | Clinical | 9.41±0.1c | 11.01±0.1c | 13.99±0.0c |
| MF-AAMU-44 | Clinical | 7.44±0.2e | 9.25±0.7e | 12.62±0.3d |
| MF-AAMU-45 | Clinical | 8.68±0.1d | 13.37±0.1c | 14.69±0.0b |
| MF-AAMU-42 | Clinical | 10.15±0.1b | 12.99±0.1b | 14.98±0.0b |
| MF-AAMU-54 | Clinical | 8.78±0.0d | 9.52±0.1e | 11.04±0.0e |
| MF-AAMU-56 | Clinical | 7.00±0.0e | 7.6±0.0e | 7.97±0.0e |
| MF-AAMU-59 | Clinical | 8.81±0.2d | 11.0±0.3c | 14.77±0.0b |
| MF-AAMU-60 | Clinical | 7.02±0.1e | 11.2±0.3c | 13.22±0.3 c |
| MF-AAMU-62 | Clinical | 8.91±0.0d | 10.32±0.0d | 12.34±0.3d |
| MF-AAMU-65 | Clinical | 7.81±0.0e | 8.90±0.0e | 11.77±0.0e |
Clinical samples were human fecal specimens obtained from a hospital. Data are mean±SEM values.
abcde: Different letters denote differences in zones of inhibition for 2.5%, 5%, and 10% sorrel.